N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation.
about
Role of bioactive fatty acids in nonalcoholic fatty liver diseaseAlcoholic Liver Disease: Update on the Role of Dietary FatLong chain polyunsaturated fatty acids (LCPUFAs) and nordihydroguaiaretic acid (NDGA) modulate metabolic and inflammatory markers in a spontaneous type 2 diabetes mellitus model (Stillman Salgado rats)Linoleic and α-linolenic fatty acid consumption over three generations exert cumulative regulation of hepatic expression of genes related to lipid metabolism.Ameliorative effects of lutein on non-alcoholic fatty liver disease in ratsFather's obesity programs the adipose tissue in the offspring via the local renin-angiotensin system and MAPKs pathways, especially in adult male mice.Palmitoleic acid (n-7) attenuates the immunometabolic disturbances caused by a high-fat diet independently of PPARαSupplementation with Docosahexaenoic Acid and Extra Virgin Olive Oil Prevents Liver Steatosis Induced by a High-Fat Diet in Mice through PPAR-α and Nrf2 Upregulation with Concomitant SREBP-1c and NF-kB Downregulation.Oleate activates SREBP-1 signaling activity in SCD1-deficient hepatocytes.Effects of rosa mosqueta oil supplementation in lipogenic markers associated with prevention of liver steatosis.Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation.Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet.
P2860
Q26739904-55D944C1-A7CB-4F4A-8A30-9B5F7D53BD22Q26769970-12767259-692A-49BB-8A04-478FDA2A7950Q28593139-70742FA0-7B08-49FA-AD81-9FA96429B157Q34212899-F451FC98-A269-4759-AD3B-BACBDE36C12EQ35843044-076191E5-1FCE-4B47-BC19-83FC177540B6Q38680361-122684E5-6238-4FC4-AC44-F98B231AD494Q41829683-058B86CE-C3FD-4636-8095-DE428B24408AQ47756379-E61895EA-5F03-4201-AA74-DD1951FC260CQ47887240-DCE0E100-F6CD-4DF2-A602-E26ED0DAFA75Q48304928-71EC603D-5B3D-4387-9091-C0DE38C2925FQ51068045-BD1B28CF-28D6-4673-BAC5-AAD07603626BQ51295444-9B568502-95A7-41AD-ACD2-CEBDE93944E2
P2860
N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
N-3 long-chain PUFA supplement ...... NF-κB DNA binding abrogation.
@en
N-3 long-chain PUFA supplement ...... NF-κB DNA binding abrogation.
@nl
type
label
N-3 long-chain PUFA supplement ...... NF-κB DNA binding abrogation.
@en
N-3 long-chain PUFA supplement ...... NF-κB DNA binding abrogation.
@nl
prefLabel
N-3 long-chain PUFA supplement ...... NF-κB DNA binding abrogation.
@en
N-3 long-chain PUFA supplement ...... NF-κB DNA binding abrogation.
@nl
P2093
P2860
P356
P1476
N-3 long-chain PUFA supplement ...... NF-κB DNA binding abrogation.
@en
P2093
Alejandra Espinosa
Amanda D'Espessailles
Camila Dossi
Daniel Gonzalez-Mañán
Gladys Tapia
Luis A Videla
Pamela Romanque
Rodrigo Valenzuela
P2860
P304
P356
10.1002/MNFR.201300458
P577
2014-01-16T00:00:00Z